Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
My Man come in Cbis and tell us it'a scam bla bla bla bla Loser
Green today as expected, riding CBIS coat tails!
Unfortunately, they just are pro.
It's hard to believe Gaines is willing to spend time in prison for Dabney ..how did she get involved with such a creep is beyond me .....
Typical Dabney no sales........ LOL :))))))
Plus, Endocan site no longer exists.
No sales ... typical dabney ?? 9.99 shopping ... omg ... try to buy ??????
) dabney lol... this was his second going to create a website to sell thx products.. lol.. cbis was #1....now the douche is collecting 5k per month to manage the research foundation sales site.. except there is none don't inhale too deeply with this creep with a vast history of stock fraud... waiting on packaging again ... 4 years of that particular story
Pointing out ENDO's one of several Pot Penny-Scams involving Ray Dabney.
Another Dabney Scam?? Jeeesh. He's got 9 lives ripping people off.
4 years Delinquent, no Financials ?!?! WTF.... Craziness!!
new to both - thanks for responding. Does it seem ambitious to want to be a penny-stock millionaire?
Are you new to buying pink stocks or just new to this board?
I just asked this question, but it applies here, as well: I'm new here. what do you mean by this statement?
I'm new here. what do you mean by this statement?
ENDO Looking good here! Yesterday was a nice rsi reset. Go ENDO!!!
The trading did seem 'suspect', but I go with the trending when there's no news. Yesterday's trading got a little too funky for me. I always try and make note of the history of buying something on no news. The historic information here left me with a quick trigger finger. Why the heck does it take so long to get these folks is beyond me.
Appears to be just another Raymond c dabney failure .. pretty scammy like all his other pot jokes ..soon enough he will be brought to justice !!!
Almost a half-mil in volume and we just opened!! Damn!!!!
$ENDO
Yes sir!!
$ENDO
Go ENDO!!! Thinking we will test the .10 and .12 resistance today! Run is a coming!!
Does anyone know why the stock is suddenly moving. Is there any news circulating somewhere? Also, does anyone think that the stock could reasonably hit one dollar a share?
VOLume uptickin..I believe we will test .10 .. Tomorrow.. Historical resistance.. Possibly break it..jmo
Good idea..Let me set up some of those 52 wk. High alerts. Thanks!
ENDO!!
What a nice close!! Just off the HOD, two days running now. Helps keep those 52-week highs hitting the scans!
I caught some NTFU's last week...went from .20 to 2.20 before pulling back today. All on MJ deal news. Ready here!
$ENDO
Is this about to do an NDEV.. Looking strong!
Looks like it started moving subtly on Friday. Interesting to watch big blocks line up on the bid as well as take out big blocks in the ask all day. With no news and no pump none-the-less.
I saw a play last week go from .20 to $2.20 on MJ related news. Someone suggested that such news might be in store here as well. Whatever the reason, it's been 'activated'.
Seeing this too..See if it can break .07 ..Then possibly .10
ENDO .. Volume building
Well I'm paying attention...even if others are not!! LoL
$ENDO
I sense a push is coming!
$ENDO
Nice pop, totally forgot I had a little bit of this! Looks like people making the CBIs connection.
Looks like it's trying to hit the radars this month. Watching curiously here.
Very interesting...inactive board. No news...yet for two days running now pps is breaking new 52-week highs on heavy relative volume.
Hmmmm.
$ENDO
Oh, presently, these companies, one's buddy acts in altogether dumping shares with the fake news, and then brand new try for building pool or try some home grow weeds? lol
We will... Kane is dumping cbis stock and it appears dabney released some bogus or incorrect lol..news regarding his Harvard deal ... lol but he ordered a hoop house ... and is looking for water lmao
Haha~~~ Let's see what litigation takes place onto them after the new president took his sworn.
They are natural born scammers, and their ways of thinking are all turd.
It's at the end now litigation after trump is sworn in it looks like
They still can't figure out if they do everyday business more honestly and more properly except criminally scamming and lying, both of us become rich by now.
I know...he's the coo now...joke....how many clowns have run this scam ....dabney is still running his Cbis disaster, I sure that will have over 3k in 4th q 16 revenue ...lmao..and they are still free men...omg
Oh boy.... Kane is still scamming in this awesome market and awesome trending sector. I give him millions of big LOL
Mhmmm ...family trust kicking foolish & loyal cbis investors butts ... says the little birdie ...lol
Working on it....Kane needs to pay for his fraud sooner or later...dabneys potion sales website is late again...wasn't that why he claimed he started Phytiva ...lmao..oh what a tangled web one weaves when deep down inside they want to be broke and locked in a cage for 20 years...lol
How has this not been suspended yet?
Welcome to the Tips, Complaints and Referrals website. The goal of this site is to provide a way for members of the public to provide information to the SEC regarding possible violations of the federal securities laws.
Thank you for coming forward with information about a possible violation of the U.S. securities laws. This questionnaire is designed to elicit the kinds of information necessary for us to best evaluate your complaint and, if appropriate, to take action.
To submit information to the SEC about possible violations of the federal securities laws, please click here or click the "Questionnaire" link, located above. Please note that we may share the information you provide with others. Read the PRIVACY ACT NOTICE to learn more about how we may use the information you send to us.
Information about the Whistleblower Award Program
The Dodd-Frank Wall Street Reform and Consumer Protection Act, signed into law by President Obama on July 21, 2010, authorizes the SEC to pay an award to eligible whistleblowers. You may be eligible for a monetary award if the information you submit leads to an SEC action that results in monetary sanctions exceeding $1,000,000. To learn more about this award program, including the eligibility requirements in the statute and final rules approved by the Commission to implement this program, please click here.
You are encouraged to submit your information in writing online by filling out the online questionnaire, available here. If you submit electronically and would like to be considered for an award under our whistleblower program, you are required to answer yes to the appropriate question on the “About you” page of the questionnaire and to electronically submit the whistleblower declaration at the end of the questionnaire. Click here to see a screen shot of the required declaration. If you wish to remain anonymous but still be eligible for an award, you must be represented by, and provide contact information for, an attorney.
If you prefer to submit your information in hard copy, you may print out the newly-available Form-TCR and submit it:
• by mail to the Office of the Whistleblower, SEC, 100 F Street, NE, Mail Stop 5971, Washington, DC 20549; or
• by fax to the Office of the Whistleblower (703) 813-9322.
OMB Number: 3235-0672
$ENDO - #Cannabis CandleGlance: http://investorshub.advfn.com/Marijuana-Public-Weed-Stocks-&-Analysis-WEED-27750/
How can a public corporation sell products and not file sec required reports...perhaps the IRS needs to be informed ...doesn't seem fair ..legal..or even a normal business practice ..Raymond c Dabney ..please advise...lmao
Followers
|
155
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9024
|
Created
|
09/04/01
|
Type
|
Free
|
Moderators |
About Endocan Corporation
The brand name Endocan(TM) was chosen by the Board as a direct reference to the endocannabinoid system of the human body. The endocannabinoid system is a group of neuromodulatory compounds and their receptors that are involved in a variety of fundamental physiological processes including pain-sensation, immune function, stress, sleep, mood, appetite, and memory. Cannabinoids from plants, including those found in the Cannabis genus, as well as those autonomously produced within living biological systems, work together in the operation of the endocannabinoid system. The modulation of this system is the basis for cannabinoid-based medical treatments to assist patients to improve their health and well-being.
Endocan Corporation, (FKA The X-Change Corporation) is currently developing new natural cannabinoid containing products based on innovative formulations to utilize the unique and potent benefits of the cannabis and hemp plants. Medicinal properties of cannabis, and hemp have been known and applied for thousands of years. With the aid of scientific research, Endocan Corporation is translating such knowledge into development of effective cannabinoid formulation-based health and wellness solutions as well as cosmeceutical, nutraceutical, and food brands throughout the world. The Company's health and wellness, nutritional, and cosmetics lines will address personal needs and will evolve with the introduction of new formulations and products, advancing the Company within the expanding multibillion-dollar global market.
"GOOD HEALTH! In an ever changing world the one thing that should be maintained is good health."
Endocan is the next stage of innovative cannabinoid-based solutions, with a focus on the health needs of people today. Globally, the diagnoses of critical ailments such as HIV/AIDS, cancer, autoimmune disease, high blood pressure, dementia, and more are arising. Despite scientific advances, we are facing a situation in which millions of people continue to be affected by life-threatening conditions with no truly effective means of treating them. The world needs smart science and research, strong leadership, and new products to respond to ever growing medical need.
Endocan utilizes the unique and potent benefits of cannabinoids, the natural compounds found in the Cannabis plants, from which cannabis and hemp are produced. Cannabinoid based products are potentially the ideal solution for many conditions and diseases.
Endocan strives to become known as one of the quintessential brands in the world, featuring multiple products, including cosmeceuticals and nutraceuticals. Cosmetics and nutrition are personal over the counter markets that continuously evolve with new formulations and products. The personal care market is estimated at $350 billion in 2012, with skin care growing approximately 7% over the next five years. The U.S. cosmeceuticals market is estimated at about $5-6 billion, while in the EU the market is worth between $3 and $5 billion. The Japanese is a market worth of about $6-8 billion.
Endocan, we believe, will capture a sizable portion of the market as Endocan becomes a household name. Endocan is poised to become known and flourish in the retail marketplace.
Endocan has something unique to offer with our formulation and innovative products and branding identity. Our formulations include natural, proprietary oil extracts to ensure the quality and effectiveness of the products.
Sales for Endocan's product lines are forecasted to grow into hundreds of millions of dollars upon realization of full global expansion and franchising opportunities.
There are over 525 natural components found in the Cannabis plant. Cannabinoids are believed to be at least 85 if not over 100 of these natural components. These components interact with specific receptors called “cannabinoid receptors.”
Two receptors have been found to date, called CB1 and CB2. The cannabinoids are separated into subclasses:
The cannabinoids mentioned most often are Tetrahydrocannabinols (THC) and Cannabidiols, for the simple reason that they are more frequently occurring in most strains and produce the most activity in the body. A substance that occurs naturally in the brain and binds to CB1 receptors was discovered in 1992 by Raphael Mechoulam’s team at the Hebrew University in Jerusalem. This substance is called “anandamide.” Other naturally occurring substances that bind to CB1 have been discovered since then. Together, they are called the “endogenous cannabinoid system” or the “endocannabinoid system.”
The cannabinoids most useful in combatting the world’s devastating illnesses are THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol), though other cannabinoids are beneficial as well. Major ailments, such as squamous and basal cell carcinomas, respond very positively to the topical application of oil extracted from the cannabis plant and containing high concentrations of THC. More about this process can be seen in our Patient Resource Center.
A major ingredient in our skincare products is hemp, which is a distant cousin to cannabis. Its main ingredient is the non-psychoactive cannabinoid called cannabidiol or CBD. Industrial hemp is characterized as being low in THC (delta-9 tetrahydrocannabinol) and high in CBD. CBD’s anti-cancer potential is currently being studied actively. It also has been shown to suppress inflammatory and neuropathic pain, exert anti-convulsant effects, and control other types of chronic pain, according to the National Center for Biotechnology Information. While CBD is important in treating certain ailments, the skin benefits most from the Omega-3 and Omega-6 essential fatty acids that are found in hemp.
The use of cannabis is thought to stretch back 4,000 years. It has been used as a medicine globally, including India, China, and the Middle East. In China, it was used to treat malaria, constipation, and rheumatism. There are even theories that cannabis use appears in the Old Testament of the Bible.
In the middle of the nineteenth century, doctors began to take an interest in it as a medicine, and it was a popular choice. Even Queen Victoria of England was given cannabis by her doctor to relieve period pains. Beginning in the early 20th century, cannabis began to be made illegal around the world, including North America and Europe.
The recreational use of cannabis has continued through today, and scientists and doctors have started studying the medicinal benefits of the plant as well. The first country to federally legalize cannabis for medicinal use was Canada in 2000. The first state in the U.S. was California in 1996. Twenty states and the District of Columbia have legalized medical cannabis in the United States and additional states are considering doing so as well.
Endocan develops products for critical ailments.
The number of diagnoses for various life-threatening diseases is rising every day. Endocan recognizes this global pandemic and is committed to with smart and sensible science.Endocan's product lines continue to mature toward critical care for people suffering from life threatening diseases like cancer and HIV. The Company's strategic research collaborations, including our strategic partners, Cannabis Science, Inc. and the medical cannabis dispensaries in legal state jurisdictions, will advance these cannabinoid-based breakthroughs in the rapidly expanding critical care market. Further, while chemotherapy and surgical treatment costs quickly rise into the hundreds of thousands of dollars per patient on an annual basis, safe, natural, and effective cannabinoid-based treatments for the same ailments are projected to cost less than ten thousand dollars per patient per annum.
Diagnoses of certain maladies are rising, and more diseases are constantly added to the medical canon. Many diseases have been classified as epidemics. The people on this planet are in dire need of something new. Endocan has identified 20 critical ailments that cannabinoids can treat and numerous skin afflictions as well. This section covers the 5 Why's and 1 How about these ailments:
Who can get them? What are they? When can a patient contract them? Where in the body do they appear, and what are the symptoms? Why do they show up? And lastly: How can cannabinoids make a difference?
Explore this section for this information, whether you are a patient, have a loved one with an illness, or are merely interested in cannabinoid science.
Endocan is dedicated to quality, respect for human life, and constant evaluation.
Respect for human life is a core value at Endocan. We believe that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. We use the latest science and technology to study these possibilities and make our products accessible to all. First, all Europe, the United States, and beyond.
Our employees are a central part of the company as well. We always take their needs into consideration. They are trained to comply with all laws and mandates. Our employees are held to high standards and rewarded for their work.
Please click on the document title to download.
Endocan Corporation 2013 Executive Summary Company Stock Symbol
XCHC - View Stock Quote
Share Structure
Common Stock
Authorized - 750,000,000
Issued - 26,746,504
Par Value - $0.001
Preferred Stock
Authorized - 100,000,000
Issued - NIL
Par Value - $0.001
Stock Transfer Agent
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: (972) 612-4120
Email: signaturestock@aol.com
http://www.endocan.com/
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |